Showing results (1-10 of 118) with videos related to
Sort By:
Pageof 12
Recent Patents on CNS Drug Discovery|January 29, 2008
Selective dopamine D3 receptor antagonists: a review 2001-2005Fabrizio Micheli, Christian HeidbrederExpert Opinion on Therapeutic Patents|January 4, 2013
Dopamine D3 receptor antagonists: a patent review (2007 - 2012)Fabrizio Micheli, Christian HeidbrederCNS & Neurological Disorders Drug Targets|January 9, 2009
Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidenceChristian HeidbrederEuropean Journal of Pharmacology|October 29, 2005
Novel pharmacotherapeutic targets for the management of drug addictionChristian HeidbrederBioorganic & Medicinal Chemistry Letters|August 10, 2010
[3-azabicyclo[3.1.0]hex-1-yl]phenyl-benzenesulfonamides as selective dopamine D3 antagonistsFabrizio Micheli, Dieter Hamprecht, Giorgio Bonanomi, et al.Chemmedchem|March 23, 2011
Recent advances in the development of dopamine D3 receptor antagonists: a medicinal chemistry perspectiveFabrizio MicheliChemmedchem|April 21, 2017
Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" RegionFabrizio MicheliCurrent Topics in Behavioral Neurosciences|January 13, 2011
Advances in animal models of drug addictionChristian HeidbrederNaunyn-Schmiedeberg'S Archives of Pharmacology|October 30, 2012
Rationale in support of the use of selective dopamine D₃ receptor antagonists for the pharmacotherapeutic management of substance use disordersChristian HeidbrederBioorganic & Medicinal Chemistry Letters|June 30, 2009
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part one: lead identificationIan P Holmes, Fabrizio Micheli, Simon Gaines, et al.Pageof 12